Found: 118
Select item for more details and to access through your institution.
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
- Published in:
- British Journal of Surgery, 2020, v. 107, n. 11, p. 1520, doi. 10.1002/bjs.11588
- By:
- Publication type:
- Article
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 1, p. 143, doi. 10.1007/s10549-018-4886-8
- By:
- Publication type:
- Article
Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of <sup>14</sup>C-plitidepsin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2018, v. 43, n. 4, p. 574, doi. 10.1111/jcpt.12661
- By:
- Publication type:
- Article
Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs.
- Published in:
- Biomedical Chromatography, 2018, v. 32, n. 4, p. 1, doi. 10.1002/bmc.4147
- By:
- Publication type:
- Article
Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Human mass balance study and metabolite profiling of C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 751, doi. 10.1007/s10637-017-0451-2
- By:
- Publication type:
- Article
Pharmacokinetics and excretion of C-Plitidepsin in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 589, doi. 10.1007/s10637-017-0432-5
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 1, p. 125, doi. 10.1002/jcph.788
- By:
- Publication type:
- Article
Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 645, doi. 10.1007/s00228-016-2030-4
- By:
- Publication type:
- Article
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α integrin inhibitor E7820 in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 329, doi. 10.1007/s10637-016-0344-9
- By:
- Publication type:
- Article
The performance of model-based versus rule-based phase I clinical trials in oncology.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2016, v. 43, n. 3, p. 235, doi. 10.1007/s10928-016-9466-0
- By:
- Publication type:
- Article
Strategies to target drugs to gliomas and CNS metastases of solid tumors.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 3, p. 428, doi. 10.1007/s00415-015-7919-9
- By:
- Publication type:
- Article
Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1197, doi. 10.1007/s10637-015-0281-z
- By:
- Publication type:
- Article
Essential medicines for breast cancer in low and middle income countries.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1583-4
- By:
- Publication type:
- Article
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2015, v. 113, n. 5, p. 706, doi. 10.1038/bjc.2015.257
- By:
- Publication type:
- Article
Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry.
- Published in:
- Veterinary & Comparative Oncology, 2015, v. 13, n. 3, p. 305, doi. 10.1111/vco.12049
- By:
- Publication type:
- Article
Essential medicines for breast cancer in low and middle income countries.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1583-4
- By:
- Publication type:
- Article
Essential medicines for breast cancer in low and middle income countries.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 591, doi. 10.1186/s12885-015-1583-4
- By:
- Publication type:
- Article
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1135, doi. 10.1007/s00280-015-2730-y
- By:
- Publication type:
- Article
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 679, doi. 10.1007/s10637-015-0235-5
- By:
- Publication type:
- Article
Inductively coupled plasma mass-spectrometric determination of platinum in excretion products of client-owned pet dogs.
- Published in:
- Veterinary & Comparative Oncology, 2015, v. 13, n. 2, p. 124, doi. 10.1111/vco.12025
- By:
- Publication type:
- Article
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 8, p. 1358, doi. 10.1038/bjc.2015.20
- By:
- Publication type:
- Article
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 4, p. 763, doi. 10.1007/s00280-015-2698-7
- By:
- Publication type:
- Article
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 9, p. 1726, doi. 10.1038/bjc.2014.467
- By:
- Publication type:
- Article
Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 146, n. 1, p. 137, doi. 10.1007/s10549-014-2999-2
- By:
- Publication type:
- Article
Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.
- Published in:
- British Journal of Cancer, 2014, v. 110, n. 11, p. 2669, doi. 10.1038/bjc.2014.222
- By:
- Publication type:
- Article
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2014, v. 110, n. 10, p. 2441, doi. 10.1038/bjc.2014.194
- By:
- Publication type:
- Article
Herb-Drug Interactions in Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 354, doi. 10.1038/clpt.2014.18
- By:
- Publication type:
- Article
Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 3, p. 477, doi. 10.1007/s10549-013-2826-1
- By:
- Publication type:
- Article
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 113, doi. 10.1007/s00280-013-2327-2
- By:
- Publication type:
- Article
Feasibility and acceptability of HIV screening through the use of rapid tests by general practitioners in a Brussels area with a substantial African community.
- Published in:
- HIV Medicine, 2013, v. 14, p. 57, doi. 10.1111/hiv.12061
- By:
- Publication type:
- Article
Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2013, v. 27, n. 17, p. 1925, doi. 10.1002/rcm.6654
- By:
- Publication type:
- Article
Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
- Published in:
- Biomedical Chromatography, 2013, v. 27, n. 9, p. 1107, doi. 10.1002/bmc.2913
- By:
- Publication type:
- Article
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 959, doi. 10.1007/s10637-013-9925-z
- By:
- Publication type:
- Article
Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 2, p. 489, doi. 10.1007/s10549-013-2532-z
- By:
- Publication type:
- Article
Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.
- Published in:
- Biomedical Chromatography, 2013, v. 27, n. 4, p. 466, doi. 10.1002/bmc.2814
- By:
- Publication type:
- Article
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 381, doi. 10.1007/s10637-012-9829-3
- By:
- Publication type:
- Article
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 823, doi. 10.1007/s00280-012-1976-x
- By:
- Publication type:
- Article
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 7, p. 1025, doi. 10.1038/bjc.2012.371
- By:
- Publication type:
- Article
Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
- Published in:
- 2012
- By:
- Publication type:
- Report
A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 10, p. 1598, doi. 10.1038/bjc.2012.154
- By:
- Publication type:
- Article
From Mouse to Man: Predictions of Human Pharmacokinetics of Orally Administered Docetaxel From Preclinical Studies.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 3, p. 370, doi. 10.1177/0091270010397051
- By:
- Publication type:
- Article
Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 25, doi. 10.1007/s00280-011-1670-4
- By:
- Publication type:
- Article
Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 768, doi. 10.1007/s10637-010-9421-7
- By:
- Publication type:
- Article